Literature DB >> 33326594

Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK).

Faye A Sharpley1, Jemma Larham1, Angus Haines1, Faouzi Djebbari1, Bing Tseu1, Heather Leary1, Grant Vallance1, Fotios Panitsas1, Lisa Ferguson1, Pamela Roberts1, Andrew Peniket1, Sarah Gooding1, Jaimal Kothari1, Sally Moore1, Karthik Ramasamy1.   

Abstract

Entities:  

Keywords:  infection; myeloma; myeloma treatment

Mesh：

Year:  2020        PMID： 33326594     DOI： 10.1111/bjh.17261

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.

Authors:  Karthik Ramasamy; Ross Sadler; Sally Jeans; Sherin Varghese; Alison Turner; Jemma Larham; Nathanael Gray; Joe Barrett; Stella Bowcock; Gordon Cook; Chara Kyriakou; Dean Smith; Mark Drayson; Supratik Basu; Sally Moore; Sarah McDonald; Sarah Gooding; Muhammad K Javaid
Journal:  Br J Haematol       Date:  2021-08-02       Impact factor: 8.615
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.